HspE7 INFECTIOUS DISEASE VACCINE FOR THE TREATMENT OF CERVICAL CARCINOMA.

Slides:



Advertisements
Similar presentations
HPV.  Many risk factors for development of cervical cancer. no routinely used positive predictive biological markers, which identify women at risk of.
Advertisements

PAPILLOMA VIRUSES. Papilloma Viruses Characteristics –dsDNA viruses (circular) –Genone 8 kbp –Genome associated with cellular histones –Naked capsid Widespread.
Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination Peter L. Stern Journal of Clinical Virology, 2005.
MANAGEMENT OF THE ABNORMAL PAP SMEAR
The Cell Cycle and Cancer. Cell signaling: chemical communication between cells. Click on above to go to animation second chemical response inside the.
Evolution of Neoplasia The Uterine Cervix As a Model Raj C. Dash, MD Duke University Medical Center Durham, North Carolina.
Cervix Dr. Raid Jastania. Cervical Cancer Screening HPV infection Pre- Cancerous Dysplasia Cancer years.
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
Cervical Cancer: Molecular Impact of an Infectious Disease.
Benign Conditions Of The Cervix Dr. Abdalla H. Elsadig MD.
Screening for Cervical Cancer
HUMAN PAPILLOMA VIRUS and CERVICAL CARCINOMA Roger J Rand.
HUMAN PAPILLOMA VIRUS (HPV) By: Nathalia Cruz. What is a Virus? ► Exceptionally simple living microbes. ► Contain a single type of nucleic acid (DNA or.
 Vulvar Diseases:  Can be divided to non-neoplastic and neoplastic diseases.  The neoplastic diseases are much less common. Of those, squamous cell.
Benign and premalignant disease of the cervix
Cervical Cancer: Prevention and Treatment
Human Papilloma virus testing Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is Human Papillomavirus? Human papilloma.
PRE-INVASIVE DISEASE OF THE CERVIX CERVICAL INTRAEPHELIAL NEOPLASIA DR. AMEL AL-SAYED Asst. Prof. & Consultant Ob/Gyne Dept.
Human Papilloma Virus. Fatima Obeidat, MD. - HPV is the most common sexually transmitted infection (STI). - HPV is so common that nearly all sexually.
Cytopathology: Technique and Interpretation
Educational Module Cervical Cancer Screening.  Estimated new cases: 610  Estimated deaths: 150 Regular Pap tests combined with the HPV vaccine can.
Viruses to Cancer What is cancer?.
HPV and Cervical Cancer Screening and Prevention.
Screening Tests for Brest & Cervical Cancer
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
Cervical Cancer Ifeoma Iwobi A CHE 350. What is Cervical cancer? Cervical cancer is a malignant neoplasm arising from cells originating in the.
Screening for Cervical Cancer by Visual Inspection Techniques Dr Aruna Batra VMMC & SJH.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Human Papilloma Virus Yasir Waheed, PhD.
What Is HPV? Human Papillomaviruses have an icosahedral shape, contain DNA, and are non-enveloped There are at least 100 different types of HPV Over 30.
Screening for Cervical Cancer Max Brinsmead MB BS PhD May 2015.
Cancer of Cervix Shashi. Sep-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. Potentially curable if detected early.
SoftPAP® A Novel Collection Device for Cervical Cytology.
P APOVAVIRUS FAMILY (P APOVAVIRIDAE ) : NOW 2 F AMILIES Papillomaviruses and Polyomaviruses.
CIN and mimics Dr Michael Coutts Consultant Gynaecological Pathologist
MEDICAL TESTING Doctor requires information Patient sample collection
Screening for cervical cancer. Screening for cervical lesions Common disease Cancer is preventable Screening is easy MUST BE PERFORMED.
Group Number: 2 Britney Porter, Sandra Nguyen, Eduardo Vargas and Samender Singh Randhawa.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
NEOPLASIA Lecture 4 Dr. Maha Arafah. Objectives List the various causes of neoplasm List the various causes of neoplasm.
NEOPLASIA Lecture 3 Maha Arafah, MD, KSFP Abdulmalik Alsheikh, M.D, FRCPC ETIOLOGY OF CANCER: CARCINOGENIC AGENTS Foundation block 2014 Pathology.
Cervical Intraepithelial Neoplasm
Cancer of Cervix Shashi. Oct-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. US Statistics: US Statistics: Leading.
Adult Medical-Surgical Nursing
Cancer as a genetic disease chapter 21 pp & lecture notes.
A non-enveloped DNA virus which infects the skin/ mucous membranes of humans.
Cervical Cancer Cervical cancer is cancer of the cervix. The cervix is the lower part of the uterus, or womb, and is situated at the top of the vagina.
Cervical cancer is the third most common cancer in women worldwide. Cervical cancer is a disease that develops quite slowly and begins with a precancerous.
Infectious etiologies of Malignancy Lalan S. Wilfong, MD Texas Oncology, PA February 4, 2004.
HPV and Cervical Cancer FAQ. What is cervical cancer? Cervical cancer is cancer of the cervix, the part of the uterus or womb that opens to the vagina.
Cervical Cancer. Female Gynecologic Cancers Cervical Cancer.
Copyright (c) by W. H. Freeman and Company
Premalignant lesions of the cervix. Applied anatomy.
1 Squamous cell carcinoma in the oral cavity and cervix Prof. Bettina Borisch, FRCPath.
Cervical Pathology Nilsa C. Ramirez, MD Director of Autopsy Pathology
Pathology of the lower female genital tract Vulvar Diseases: Can be divided to non-neoplastic and neoplastic diseases. The neoplastic diseases are much.
Will Pap Smears become a thing of the past? J. L. Ellis, M.D.
HPV AND WOMEN’S CANCER A.C. Evans. M.D., Ph.D.. HPV and Women’s Cancer I have no relevant financial relationships with the manufacturer(s) of any commercial.
EUKARYOTIC CELL SIGNALING VII Abnormal Signaling in Cancer Signaling to p53 Dr. Ke Shuai Office: 9-240M Factor Tel: X69168
Cytopathology Feb
New Technologies in cervical cancer screening Cosette Wheeler, University of New Mexico Albuquerque, New Mexico.
Chapter 29 Human Papilloma Virus Infection and Immunity.
CERVIX.
Papillomaviruses Papillomaviridae
Neoplasia of the cervix
HUMAN PAPILLOMA VIRUS and CERVICAL CARCINOMA
Objectives: 1. Cancer and the cell cycle checkpoints, reqmts to advance oncogenes tumor suppressor genes 2. 6 Traits of cancerous cells 3. Facts on.
Presentation transcript:

HspE7 INFECTIOUS DISEASE VACCINE FOR THE TREATMENT OF CERVICAL CARCINOMA

What are the Etiologic Agents for Cervical Carcinoma? n Epidemiological studies suggest that 90% of all cervical carcinomas and their associated precursor lesions are caused by Human Papillomavirus (HPV) n Variety of immunological cofactors and molecular events must take place between when an HPV infection occurs and a cervical cancer or its precursor develops

What are the Risk Factors for Developing Cervical Carcinoma? n Number of sexual partners n young age at first intercourse n early age of parity n cigarette smoking

Human Papillomaviruses n 110 HPV types have been described n Not all HPVs have oncogenic potential n HPV 6, 11, 42, 43, 44 cause the lesions associated with low oncogenic-risk group (LSIL) n HPV 16, 18, 31, 33, 35 39, 45, 51, 52, 56, 58 form the lesions associated with high oncogenic-risk group (HSIL) n HPV 18 is associated with adenocarcinoma and small- cell neuroendocrine tumors

Natural History of HPV Infection n HPV is an obligatory intranuclear organism that must infect immature mitotically active cells in order to establish itself in the epithelium n targets the squamous-columnar junction of the cervix n referred to as a “wart” or condyloma acuminata n lesions may regress or progress to invasive carcinoma n Not uncommon for an epithelium to be infected by more than one HPV type, especially in low-risk group n High-risk group multiple HPV types are infrequent

The Interaction of the HPV Genome with its Host Cell n HPV infects mitotically active immature epithelial cells n Results in a latent infection where viral DNA resides in the host nucleus and replication is tied to the cell cycle n Latent Infections: may convert to a replicative infections the signal to initiate this conversion is not known can not be detected morphologically can be detected only by molecular techniques

HPV Replicative Infections n Unclear to amount of HPV virions that are produced and shed during replicative phase n Larger number of viral particles are found in increasing amounts as the cell matures n It is the mature epithelial cell that shows morphologic characteristics used in diagnostic cytology (Pap smear)

Conventional Detection Methods Papanicolaou smear (Pap) – clinician takes a cellular sample from the squamous-columnar junction of the cervix and puts it on a slide – cytology lab stains and examines the specimen under the microscope for cellular abnormalities

Condyloma Acuminata

Morphologic Features of HPV

CIN I

CIN II & CIN III

CIS

Squamous Cell Carcinoma

Endocervical Adenocarcinoma

Small Cell Carcinoma

Molecular Events of HPV Oncogenesis n HPV types in high oncogenic risk groups produce E6 & E7 proteins that transform normal cells to neoplastic cells n E6 & E7 proteins deregulate the normal process of mitotic division by interfering with proteins of the normal feedback loops of cell division n E6-encoded protein binds to p53 (tumor suppressor) causing its inactivation and increasing its rate of degradation in the E/6p53 protein complex n E7 binds to the cyclin Ap107 protein and the retinoblastoma gene product, p105RB

HPV Oncogenesis n This neoplastic transformation is accompanied by mutations in 5 or more key mitotic regulatory proteins (p53, retinoblastoma, cyclin, etc.) n When cells are allowed to complete repeated mitotic cycles with mutations intact, there is a gradual accumulation of mutated genes n When a sufficient number of alterations in regulatory sequences have accumulated and an insufficient number of redundant regulatory pathways survive, the cell will be transformed neoplastically

Conventional Treatment n Cold cautery (liquid nitrogen freezing of tissue) n Hot cautery (burning of tissue) n Laser n Conventional surgery n Chemicals applied directly podophyllin trichloroacetic acid

New Treatment for Cervical Carcinoma Oncocine HspE7 n Developed by StressGen Biotechnologies Corp. n Therapeutic vaccine designed to treat patients who have cervical carcinoma n preclinical studies have shown complete regression of large existing tumors and protection against reoccurrence n Phase I clinical trial will treat patients with CIN II/III lesions to determine if HspE7 can be safely tolerated

What is Oncocine HspE7 n It is a recombinant protein composed of the M. bovis BCG stress protein 65 and the E7 protein from HPV 16 n Therapy is based on the use of stress proteins and stress protein genes to stimulate the body’s own immune defenses to fight disease

How does HspE7 work? n E7 protein is responsible for the transformation of HPV infected cells in to cancer cells n Demonstrated that foreign stress proteins(p65), fused to a wide variety of antigens(E7), can generate stronger T cell & B cell immune response n E7 protein is continuously expressed in cervical cancer cells, making it an ideal target for StressGen’s technology

Conclusion n Estimated between 300,000 and 1.5 million women in the US are diagnosed annually with HPV-induced abnormal cervical epithelial cells n Current treatment is not always effective n StressGen’s approach has the potential to immunologically target virally transformed cells specifically, reducing recurrence and the need for surgery

FUTURE TRENDS n If HPV vaccines are successful, we should see a marked decrease in the incidence of CIN and cervical cancers n A vaccine directed against HPV 16 alone would save the lives of 225,000 women yearly worldwide n A vaccine directed against HPV 16 and HPV 18 would decrease the incidence most cervical carcinomas